BioMed Research International / 2015 / Article / Fig 3

Research Article

Hepatocyte-Specific Ablation of PP2A Catalytic Subunit α Attenuates Liver Fibrosis Progression via TGF-β1/Smad Signaling

Figure 3

PP2Acα deletion inhibited HSC activation. (a) Immunohistochemical analysis of α-SMA expression in liver tissues from the control and PP2Acα knockout mice at 5 weeks after the chronic CCl4 treatment. Magnification, ×100. Bar, 50 μm. The histogram shows the mean percentage of the α-SMA positive area per total liver area determined from five randomly selected fields. Values are means ± SD, . . (b) Western blot analyses of hepatic α-SMA expression in the control and PP2Acα knockout mice at 5 weeks after the chronic CCl4 treatment. Liver homogenates were probed with antibodies against α-SMA and β-actin, respectively.
(a)
(b)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.